Prognostic impact of baseline serum C-reactive protein in patients with metastatic renal cell carcinoma (RCC) treated with sunitinib-Reference-Cited by-同舟云学术

Prognostic impact of baseline serum C-reactive protein in patients with metastatic renal cell carcinoma (RCC) treated with sunitinib

Published:2014-01-15 Issue:1 Volume:114 Page:81-89
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Beuselinck Benoit¹²,Vano Yann-Alexandre³,Oudard Stéphane³,Wolter Pascal¹,De Smet Robert¹,Depoorter Lore¹,Teghom Corine³,Karadimou Alexandra²,Zucman-Rossi Jessica²,Debruyne Philip R.⁴,Van Poppel Hendrik⁵,Joniau Steven⁵,Lerut Evelyne⁶,Strijbos Michiel¹,Dumez Herlinde¹,Paridaens Robert¹,Van Calster Ben⁷,Schöffski Patrick¹

Affiliation:

1. Department of General Medical Oncology and Laboratory for Experimental Oncology; University Hospitals Leuven; Leuven Cancer Institute; KU Leuven; Leuven Belgium

2. Inserm U674 Génomique fonctionnelle des tumeurs solides; Université Paris-5 René Descartes; Paris France

3. Department of Medical Oncology; Georges Pompidou European Hospital; Université Paris-5 René Descartes; Paris France

4. Department of Medical Oncology; AZ Groeninge; Kortrijk Belgium

5. Department of Urology; KU Leuven; Leuven Belgium

6. Department of Pathology; KU Leuven; Leuven Belgium

7. Department of Biostatistics Section; Department of Development and Regeneration; KU Leuven; Leuven Belgium

Funder

Fondation Martine Midy

Research Foundation - Flanders (FWO)

Hellenic Society of Medical Oncology

Fonds voor Wetenschappelijk Onderzoek Vlaanderen

Stichting tegen Kanker

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bju.12494/fullpdf

Reference40 articles.

1. Global cancer statistics, 2002;Parkin;CA Cancer J Clin,2005

2. Cancer statistics, 2006;Jemal;CA Cancer J Clin,2006

3. Novel approaches in the therapy of metastatic renal cell carcinoma;Lam;World J Urol,2005

4. US National Institutes of Health Surveillance, Epidemiology and End Results (SEER) Cancer Statistics Review. Kidney and Renal Pelvis Cancer. 5-Year Relative Survival Rates, 1996-2002

5. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma;Motzer;N Engl J Med,2007

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Candidate biomarkers for treatment benefit from sunitinib in patients with advanced renal cell carcinoma using mass spectrometry-based (phospho)proteomics;Clinical Proteomics;2023-11-08

2. Association between a novel nutrition‐inflammation prognostic grading system and overall survival in hospitalized adults with cancer: A retrospective cohort study;Journal of Parenteral and Enteral Nutrition;2023-11-07

3. Sequencing impact and prognostic factors in metastatic castration-resistant prostate cancer patients treated with cabazitaxel: A systematic review and meta-analysis;Urologic Oncology: Seminars and Original Investigations;2023-04

4. Efficacy and Safety of Cabozantinib in Patients with Advanced or Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Cohort Study;Biomedicines;2022-12-07

5. Logical Imputation to Optimize Prognostic Risk Classification in Metastatic Renal Cell Cancer;Kidney Cancer;2022-11-18